Patrick G. Enright
Director
business management
Jazz Pharmaceuticals
United States of America
Biography
Patrick G. Enright has served as a member of our board of directors since July 2009. Since 2006, Mr. Enright has served as a Managing Director of Longitude Capital, a venture capital firm, of which he is a founder. From 2002 through 2006, Mr. Enright was a Managing Director of Pequot Ventures, a venture capital investment firm, where he co-led the life sciences investment practice. He currently serves on the boards of directors of Aimmune Therapeutics, Inc., a biopharmaceutical company, and several privately held companies. Previously, Mr. Enright served on the board of directors of Esperion Therapeutics, Inc., a pharmaceutical company, from April 2013 to June 2016 and Corcept Therapeutics Incorporated, a pharmaceutical company, from April 2008 to May 2017. Mr. Enright received a B.S. from Stanford University and an M.B.A. from the Wharton School at the University of Pennsylvania.
Research Interest
economics,accounting
